UF Health Cancer Center Researcher Showcases a New Vaccine That Can Help Fight Diseases
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey introduces us to the researcher developing a groundbreaking mRNA vaccine with the potential to fight cancer and infectious diseases.
MBI Researchers to Test Novel Treatments for Medulloblastoma
University of Florida researchers have received approval from the Food and Drug Administration to test two new experimental therapies in first-ever human clinical trials for a subtype of medulloblastoma, the most common pediatric malignant brain tumor.
UF-Developed mRNA Vaccine Triggers Fierce Immune Response To Fight Malignant Brain Tumor
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.
UF Pediatric Oncologist Awarded v Foundation Grant for Pediatric Osteosarcoma Study
University of Florida Health pediatric oncologist John A. Ligon, M.D., has been awarded a $600,000 grant from the V Foundation for Cancer Research to study a personalized immunotherapy vaccine to treat relapsed pediatric osteosarcoma.
UF Health Research To Create Cancer Vaccine Gets $2.5M in New Funding
The Pediatric Cancer Foundation’s Cure-Search for Children’s Cancer is funding UF's Dr. Elias Sayour’s efforts to create a novel vaccine to treat brain cancer in children.
Hot Tumors: The Turbo Engine That Immunotherapy Needed
Immunotherapy is a hot topic of conversation when it comes to cancer treatment. Pediatric oncologist Dr. Elias Sayour and his team have found a way to make a hot tumor, their way to make immunotherapy, an alternative to chemotherapy, more effective.
UF Researcher Will Lead CureSearch for Children’s Cancer $1 Million Gift To Support Cutting-Edge Immunotherapy Trial for Pediatric High-Grade Glioma
CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors. The project is funded through a CureSearch Catapult Award granted to pediatric oncologist Elias Sayour, MD, Ph.D. at the University of Florida.
